infectious

Persistent Fever Despite Broad-Spectrum Antibiotics

Evaluating unresolved fever after 48–72 hours of antimicrobial therapy: undrained closed-space infection, resistant/fungal pathogens, catheter infections, C. difficile, drug fever, and ICU thrombosis.

Persistent or recurrent fever after 48 to 72 hours of empiric broad-spectrum antibiotic therapy is a frequent, perplexing ICU challenge. Reflexively broadening antibacterial coverage without a systematic anatomic and microbiological audit is a major clinical trap that selects for multidrug-resistant pathogens and fungal superinfections. The bedside priority is to systematically evaluate the 6 cardinal mechanisms of antimicrobial failure: undrained anatomical source, inadequate PK/PD dosing, resistant or non-bacterial pathogens, catheter/hardware biofilm, drug fever, and non-infectious inflammatory triggers.

Caution

Dangerous Diagnosis Not to Miss: Undrained Loculated Abscess (subdiaphragmatic, pelvic, psoas, or retroperitoneal), Empyema / Parapneumonic Effusion, Infective Endocarditis with valvular destruction, Suppurative Thrombophlebitis / Septic Thrombosis (Lemierre syndrome or infected central line thrombus), Invasive Candidiasis, and Fulminant Clostridioides difficile Colitis.

THE 6 CARDINAL MECHANISMS OF ANTIMICROBIAL FAILURE

1. Undrained Closed-Space Infection (Source Control Failure): Antibiotics cannot penetrate thick fibrous capsules, low pH abscess cavities, or dense necrotic tissue.
2. Indwelling Device Biofilm: Microorganisms embedded in glycocalyx on central venous catheters, urinary catheters, endotracheal tubes, or orthopedic hardware.
3. Resistant or Non-Bacterial Pathogens: Methicillin-resistant S. aureus (MRSA), Vancomycin-resistant Enterococcus (VRE), Carbapenem-resistant Enterobacterales (CRE), MDR Pseudomonas, Stenotrophomonas maltophilia, Candida albicans / auris, Aspergillus, CMV, HSV.
4. Pharmacokinetic / Pharmacodynamic (PK/PD) Underdosing: Augmented renal clearance (ARC: CrCl > 130 mL/min) or high volume of distribution leading to subtherapeutic antibiotic troughs.
5. Drug-Induced Fever: Offending antibiotics (beta-lactams, vancomycin, sulfonamides), anticonvulsants (phenytoin, carbamazepine), or heparin.
6. Non-Infectious ICU Inflammation: Venous thromboembolism (DVT/PE), acute pancreatitis, acalculous cholecystitis, intracranial fever, hematoma resorption.

SYSTEMATIC STEP-BY-STEP DIAGNOSTIC AUDIT

Repeat blood cultures when persistent bacteremia/fungemia is plausible; sample catheter lumens and peripheral blood as appropriate to the suspected source.
Use targeted imaging rather than an automatic 'pan-scan':
- CT abdomen/pelvis with IV contrast when an occult intra-abdominal source, leak, ischemia, abscess, pancreatitis or acalculous cholecystitis is plausible.
- CT chest when empyema, lung abscess, cavitation or septic pulmonary emboli are plausible.
- Echocardiography when organism-, host- or course-specific features raise concern for endocarditis; do not teach TTE/TEE as universally mandatory for every Candida or Enterococcus bloodstream infection.
- Vascular ultrasound when DVT or septic thrombophlebitis is clinically suspected.

LINE MANAGEMENT & HARDWARE AUDIT

Central venous catheters: do not remove solely because the catheter has been present for 5–7 days. If it is a plausible source of sepsis, obtain appropriate cultures and remove it promptly after alternative access is established when organism, tunnel/port infection, persistent bacteremia or clinical instability makes removal appropriate.
Urinary catheter: remove when no longer indicated. For symptomatic CAUTI with a long-standing catheter, follow CAUTI/local guidance for replacement rather than using a universal 7-day threshold.

PHARMACOKINETIC & ANTIMICROBIAL OPTIMIZATION

REASSESSMENT & ANTIMICROBIAL TIME-OUT

Caution

Common Diagnostic Trap: Continually escalating antibacterial coverage without reassessing source control, device infection, resistant or fungal infection, drug fever, thrombosis, ischemia and other noninfectious causes. Persistent ICU fever should trigger a structured diagnostic reassessment rather than an unsupported assumption that most cases are due to an occult abscess or line infection.

Destination Topics

Sepsis: Source control timelines and immune dysregulation.
Catheter Infections: Catheter-related bloodstream infections, line removal criteria, and lock therapy.
C. difficile: Toxic megacolon, diagnostic algorithms, and oral vancomycin.
Antimicrobial Stewardship: PK/PD beta-lactam dosing and antifungal stewardship.
Intra-Abdominal Hypertension: Tertiary peritonitis and abdominal compartment syndrome.
VAP & HAP: Cavitary pneumonia, empyema, and resistant Gram-negative pathogens.

Evidence status

Review metadata not yet recorded.

Status, review dates and guideline versions appear here once editorial metadata is authored for this content.

Actionable Clinical Workflows (14)

Step-by-step ICU Processes

Initial Hemodynamic Resuscitation & Shock Bundling

From recognizing hypoperfusion and initial crystalloid bolus to dynamic fluid responsiveness assessment and vasopressor targets.

Launch Workflow →

Shock

Initial resuscitation and classification once shock is established.

Launch Workflow →

Renal Replacement Therapy & CRRT Initiation

From urgent 'AEIOU' indication screening and modality selection to vascular access, dosing, and anticoagulation.

Launch Workflow →

Severe Hyperkalemia Emergency Management

From emergent cardiac membrane stabilization to intracellular shifting, elimination, and dialysis triggers.

Launch Workflow →

Deep-Dive Topic Destinations (7)

Reference Knowledge

Sepsisinfectious-disease

Life-threatening organ dysfunction caused by a dysregulated host response to infection — recognized by an acute rise in SOFA score, not by infection plus fever alone.

Explore Topic →

Multidrug-Resistant (MDR) Pathogens & IDSA AMR Guidanceinfectious-disease

Molecular resistance mechanisms (ESBL, AmpC, KPC, NDM, OXA-48, DTR-Pseudomonas, CRAB), the MERINO trial, and modern novel beta-lactamase inhibitor therapeutics.

Explore Topic →

Necrotizing Soft Tissue Infections (NSTI)infectious-disease

A surgical source-control emergency: recognize rapidly progressive deep infection, involve surgery immediately, start broad antimicrobials, resuscitate shock, and re-explore until source control is complete.

Explore Topic →

Acute Meningitis & Encephalitisneurology

CT-before-LP criteria, CSF interpretation matrix, de Gans Dexamethasone timing, empiric age/host antimicrobial coverage + Ampicillin + Acyclovir, and neurocritical ICP management.

Explore Topic →

Acute Kidney Injury in Critical Carerenal

Sepsis-AKI microcirculatory decoupling, KDIGO staging, Furosemide Stress Test (FST), urine microscopy, and the AEIOU dialysis threshold framework.

Explore Topic →

Ventilator-Associated Pneumonia (VAP)infectious-disease

Quantitative lower tract sampling (ETA vs BAL), rapid multiplex PCR panels and stewardship interpretation, PK/PD extended beta-lactams, 7-day duration, and the SHEA prevention bundle.

Explore Topic →

Hospital-Acquired Pneumonia (HAP)infectious-disease

Nosocomial pneumonia developing ≥ 48 hours after admission in non-ventilated patients, host and antibiogram MDR risk tailoring, nasal MRSA PCR screening, and 7-day de-escalation.

Explore Topic →